Developing allogeneic double negative T cells as a novel off-the-shelf adoptive cellular therapy for cancer.

CONCLUSION: We have established a method to generate therapeutic numbers of clinical-grade DNTs that fulfill the requirements of an off-the-shelf ACT.
PMID: 30617140 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - January 7, 2019 Category: Cancer & Oncology Authors: Lee JB, Kang H, Fang L, D'Souza C, Adeyi O, Zhang L Tags: Clin Cancer Res Source Type: research